| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.800 | limited | 0.955 | 106 | 3 | 2009 | 2019 | ||||||||
|
interferon regulatory factor 1 | 0.468 | 0.769 | 0.99 |
|
disease | 0.380 | limited | 0.875 | 8 | 0 | 1993 | 2011 | ||||||||
|
acyl-CoA synthetase long chain family member 6 | 0.686 | 0.500 | 3.2E-03 |
|
disease | 0.320 | limited | 1.000 | 2 | 0 | 1999 | 2016 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.800 | moderate | 0.955 | 148 | 7 | 1989 | 2019 | ||||||||
|
RAD51 recombinase | 0.447 | 0.846 | 2.7E-02 |
|
disease | 0.400 | moderate | 0.917 | 11 | 0 | 2004 | 2017 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.800 | strong | 0.985 | 442 | 5 | 1991 | 2020 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.400 | strong | 0.958 | 143 | 0 | 1982 | 2020 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.800 | strong | 0.981 | 52 | 0 | 1995 | 2019 | ||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
disease | 0.700 | strong | 1.000 | 17 | 0 | 2002 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.700 | strong | 1.000 | 13 | 3 | 2003 | 2018 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.530 | strong | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.330 | strong | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
ERCC excision repair 4, endonuclease catalytic subunit | 0.468 | 0.846 | 1.4E-12 |
|
disease | 0.320 | strong | 0.667 | 2 | 0 | 2015 | 2017 | ||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
disease | 0.520 | strong | 1.000 | 2 | 1 | 2003 | 2016 | ||||||||
|
SBDS ribosome maturation factor | 0.601 | 0.692 | 6.2E-05 |
|
disease | 0.620 | strong | 1.000 | 2 | 0 | 2005 | 2017 | ||||||||
|
FA complementation group F | 0.535 | 0.731 | 0.46 |
|
disease | 0.510 | strong | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
disease | 0.510 | strong | 1.000 | 1 | 0 | 2016 | 2017 | ||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 1999 | 2017 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 1.000 | definitive | 0.985 | 180 | 2 | 1992 | 2020 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 1.000 | None | 0.985 | 1058 | 10 | 1992 | 2020 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.991 | 419 | 0 | 1993 | 2020 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.983 | 396 | 0 | 1996 | 2020 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
disease | 0.400 | None | 0.986 | 284 | 4 | 1993 | 2020 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 0.963 | 243 | 0 | 1988 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.961 | 224 | 10 | 1986 | 2020 |